# International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia

> **NCT01117441** · PHASE3 · COMPLETED · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 6136 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** PEG-L-asparaginase
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin hydrochloride
- **DRUG:** dexamethasone
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** mercaptopurine
- **DRUG:** methotrexate
- **DRUG:** prednisone
- **DRUG:** thioguanine
- **DRUG:** vincristine sulfate
- **DRUG:** vindesine
- **DRUG:** daunoxome
- **DRUG:** fludarabine
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT01117441
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 6136 (ACTUAL)
- **Last updated:** 2022-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117441, "International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01117441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*